高级检索
    肖志坚, 陆泽生. 氯法拉滨与氯法拉滨联合小剂量阿糖胞苷对老年急性髓性白血病及高危骨髓增生异常综合征随机对照研究[J]. 循证医学, 2009, 9(5): 263-265. DOI: 10.3969/j.issn.1671-5144.2009.05.009
    引用本文: 肖志坚, 陆泽生. 氯法拉滨与氯法拉滨联合小剂量阿糖胞苷对老年急性髓性白血病及高危骨髓增生异常综合征随机对照研究[J]. 循证医学, 2009, 9(5): 263-265. DOI: 10.3969/j.issn.1671-5144.2009.05.009
    shu
    XIAO Zhi-jian, LU Ze-sheng. A Randomized Study of Clofarabine Versus Clofarabine Plus Low-Dose Cytarabine us Front-Line Therapy for Older Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 263-265. DOI: 10.3969/j.issn.1671-5144.2009.05.009
    Citation: XIAO Zhi-jian, LU Ze-sheng. A Randomized Study of Clofarabine Versus Clofarabine Plus Low-Dose Cytarabine us Front-Line Therapy for Older Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome[J]. Journal of Evidence-Based Medicine, 2009, 9(5): 263-265. DOI: 10.3969/j.issn.1671-5144.2009.05.009
    shu

    氯法拉滨与氯法拉滨联合小剂量阿糖胞苷对老年急性髓性白血病及高危骨髓增生异常综合征随机对照研究

    A Randomized Study of Clofarabine Versus Clofarabine Plus Low-Dose Cytarabine us Front-Line Therapy for Older Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回